- Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease. Teshima, T., Reddy, P., Lowler, K.P., KuKuruga, M.A., Liu, C., Cooke, K.R., Ferrara, J.L. Blood (2002)